Validation of a Community Pharmacy-Based Prescription Drug Monitoring Program Risk Screening Tool (PHARMSCREEN)
Sponsor: National Institute on Drug Abuse (NIDA)
A observational or N/A phase clinical study on Opioid Abuse and Prescription Drug Abuse (Not Dependent), this trial is completed. The trial is conducted by National Institute on Drug Abuse (NIDA) and has accumulated 12 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Aug 2024 — Sep 2024 [monthly]
Completed
-
Jul 2024 — Aug 2024 [monthly]
Completed
-
Jul 2023 — Jul 2024 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Jul 2022 — Jul 2023 [monthly]
Active Not Recruiting
▶ Show 7 earlier versions
-
Dec 2021 — Jul 2022 [monthly]
Active Not Recruiting
-
Jun 2021 — Dec 2021 [monthly]
Active Not Recruiting
-
Jan 2021 — Jun 2021 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Oct 2020 — Nov 2020 [monthly]
Recruiting
-
Feb 2020 — Oct 2020 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Jun 2019 — Feb 2020 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- National Institute on Drug Abuse (NIDA)
- Purdue University
- University of Cincinnati
- University of Utah
For direct contact, visit the study record on ClinicalTrials.gov .